157 related articles for article (PubMed ID: 37973648)
1. Awareness and Candidacy for Endocrine Prevention and Risk Reducing Mastectomy in Unaffected High-Risk Women Referred for Breast Cancer Risk Assessment.
Alhassan B; Rjeily MB; Villareal-Corpuz V; Prakash I; Basik M; Boileau JF; Martel K; Pollak M; Foulkes WD; Wong SM
Ann Surg Oncol; 2024 Feb; 31(2):981-987. PubMed ID: 37973648
[TBL] [Abstract][Full Text] [Related]
2. Risk-reducing mastectomy for the prevention of primary breast cancer.
Carbine NE; Lostumbo L; Wallace J; Ko H
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD002748. PubMed ID: 29620792
[TBL] [Abstract][Full Text] [Related]
3. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
Franceschini G; Di Leone A; Terribile D; Sanchez MA; Masetti R
Ann Ital Chir; 2019; 90():1-2. PubMed ID: 30872561
[TBL] [Abstract][Full Text] [Related]
4. Differences among a Portuguese cohort of BRCA pathogenic/likely pathogenic variants carriers choosing risk-reducing mastectomy or intensive breast surveillance.
Torres S; Peleteiro B; Magalhães A; Garrido L; Costa S; Fougo JL
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7529-7538. PubMed ID: 36971799
[TBL] [Abstract][Full Text] [Related]
5. Surgical Decision Making in Genetically High-Risk Women: Quantifying Postoperative Complications and Long-Term Risks of Supplemental Surgery After Risk-Reducing Mastectomy.
Apostolova C; Ferroum A; Alhassan B; Prakash I; Viezel-Mathieu A; Basik M; Boileau JF; Meterissian S; Wong N; Foulkes WD; Wong SM
Ann Surg Oncol; 2024 Jan; 31(1):356-364. PubMed ID: 37838650
[TBL] [Abstract][Full Text] [Related]
6. Reasons for risk-reducing mastectomy versus MRI-screening in a cohort of women at high hereditary risk of breast cancer.
Haroun I; Graham T; Poll A; Sun P; Hill K; Weitzner E; Narod S; Warner E
Breast; 2011 Jun; 20(3):254-8. PubMed ID: 21306899
[TBL] [Abstract][Full Text] [Related]
7. Specialty Care and Counselling about Hereditary Cancer Risk Improves Adherence to Cancer Screening and Prevention in Newfoundland and Labrador Patients with
Roebothan A; Smith KN; Seal M; Etchegary H; Dawson L
Curr Oncol; 2023 Oct; 30(10):9367-9381. PubMed ID: 37887578
[TBL] [Abstract][Full Text] [Related]
8. Is family history related to preventive health behaviors and medical management in breast cancer patients?
Madlensky L; Flatt SW; Bardwell WA; Rock CL; Pierce JP;
Breast Cancer Res Treat; 2005 Mar; 90(1):47-54. PubMed ID: 15770526
[TBL] [Abstract][Full Text] [Related]
9. Trends and timing of risk-reducing mastectomy uptake in unaffected BRCA1 and BRCA2 carriers in Slovenia.
Ložar T; Žgajnar J; Perhavec A; Blatnik A; Novaković S; Krajc M
Eur J Surg Oncol; 2021 Aug; 47(8):1900-1906. PubMed ID: 33812767
[TBL] [Abstract][Full Text] [Related]
10. Timing of genetic testing in BRCA1/2 and PALB2-Associated breast cancer: Preoperative result disclosure increases uptake of risk-reducing mastectomy and reduces unnecessary exposure to radiotherapy.
Apostolova C; Ferroum A; Alhassan B; Prakash I; Basik M; Boileau JF; Martel K; Meterissian S; Villareal Corpuz V; Wong N; Foulkes WD; Wong SM
Eur J Surg Oncol; 2024 Jun; 50(6):108324. PubMed ID: 38636249
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic mastectomy for the prevention of breast cancer.
Lostumbo L; Carbine N; Wallace J; Ezzo J
Cochrane Database Syst Rev; 2004 Oct; (4):CD002748. PubMed ID: 15495033
[TBL] [Abstract][Full Text] [Related]
13. Cost-Effectiveness of Gene-Specific Prevention Strategies for Ovarian and Breast Cancer.
Wei X; Sun L; Slade E; Fierheller CT; Oxley S; Kalra A; Sia J; Sideris M; McCluggage WG; Bromham N; Dworzynski K; Rosenthal AN; Brentnall A; Duffy S; Evans DG; Yang L; Legood R; Manchanda R
JAMA Netw Open; 2024 Feb; 7(2):e2355324. PubMed ID: 38334999
[TBL] [Abstract][Full Text] [Related]
14. Patient and medical barriers preclude uptake of tamoxifen preventative therapy in women with a strong family history.
Skandarajah AR; Thomas S; Shackleton K; Chin-Lenn L; Lindeman GJ; Mann GB
Breast; 2017 Apr; 32():93-97. PubMed ID: 28107734
[TBL] [Abstract][Full Text] [Related]
15. Uptake and timing of bilateral and contralateral risk-reducing mastectomy in women with Li-Fraumeni syndrome.
Siegel A; Bremer RC; Klein WMP; Savage SA; Loud JT; Khincha PP
Breast Cancer Res Treat; 2022 Jan; 191(1):159-167. PubMed ID: 34652547
[TBL] [Abstract][Full Text] [Related]
16. Intentions for risk-reducing surgery among high-risk women referred for BRCA1/BRCA2 genetic counseling.
Tong A; Kelly S; Nusbaum R; Graves K; Peshkin BN; Valdimarsdottir HB; Wood M; McKinnon W; Garber J; McCormick SR; Jandorf L; Schwartz MD
Psychooncology; 2015 Jan; 24(1):33-9. PubMed ID: 24839250
[TBL] [Abstract][Full Text] [Related]
17. Cancer screening with digital mammography for women at average risk for breast cancer, magnetic resonance imaging (MRI) for women at high risk: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(3):1-55. PubMed ID: 23074406
[TBL] [Abstract][Full Text] [Related]
18. Risk-reducing surgery in BRCA1/BRCA2 mutation carriers: Are there factors associated with the choice?
Manoukian S; Alfieri S; Bianchi E; Peissel B; Azzollini J; Borreani C
Psychooncology; 2019 Sep; 28(9):1871-1878. PubMed ID: 31264307
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic bilateral mastectomy for breast cancer prevention.
Metcalfe KA
J Womens Health (Larchmt); 2004 Sep; 13(7):822-9. PubMed ID: 15385076
[TBL] [Abstract][Full Text] [Related]
20. Counselling Framework for Germline
Wong SM; Apostolova C; Eisenberg E; Foulkes WD
Curr Oncol; 2024 Jan; 31(1):350-365. PubMed ID: 38248108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
